In 1954, English composer Benjamin Britten and librettist Myfawnwy Piper debuted their own version of the story reshaped as a ...

In the EU, GOHIBIC (vilobelimab) has been granted marketing authorization under exceptional circumstances for the treatment ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that ...

The WisdomTree U.S. LargeCap Fund ETF offers earnings-based exposure, outperforming the S&P 500. Read why I reiterate my Buy ...

NovelMed announce positive 12-week interim results from phase II trial of Ruxoprubart in adult patients with PNH: Cleveland Wednesday, May 21, 2025, 12:00 Hrs [IST] NovelMed, a cl ...

The acquisition would significantly boost Novartis’ position in rare kidney disease IgA nephropathy (IgAN), which the Swiss big pharma is targeting with oral complement factor B inhibitor ...

Consuming certain spices, such as chili pepper, turmeric, ginger, and cinnamon, may positively affect metabolism and help ...

CLEVELAND, May 19, 2025 (GLOBE NEWSWIRE) -- NovelMed is pleased to announce positive 12-week interim results from the ongoing multi-dose Phase II trial of Ruxoprubart, a novel complement-targeting ...

The factor B inhibitor also allowed significantly more ... with regulators so we can bring this first-in-class alternative complement pathway inhibitor as the first oral monotherapy to people ...

Bring your Tigers football, basketball and recruiting questions, and talk to Eli Hoff in a live chat at 11 a.m. Thursday.

Firetail Resources has increased its gold exposure through an option to acquire two high-grade projects in tier-1 ...

Discover the richest sources of vitamin B12 including shellfish, organ meats, dairy products, and fortified options that help ...